cardiology careers collections past issues search home
     

Right arrow Help viewing high resolution images
Right arrow Return to article

Please click here to obtain permission to reproduce this image.

Click on image to view larger version.


Figure 1


Figure 1 Assessment of Spontaneous NF-{kappa}B Activation in Circulating Monocytes (Protocol A)

(A) Electrophoresis mobility shift assay (EMSA). In each patient, freshly isolated peripheral blood monocytes (5 x 105) were analyzed for the spontaneous presence of activated nuclear factor (NF)-{kappa}B complexes in their nuclei by EMSA in the presence of anti-p50 subunit monoclonal antibodies or isotype-matched control IgG antibodies. As a positive control (Pos) nuclear extracts were generated from 5 x 105 monocytes incubated for 30 min with 10 ng/ml lipopolysaccharide (LPS), and as a negative control (Neg) nuclear extracts were generated from 5 x 105 monocytes incubated for 30 min with phosphate-buffered solution only. NF-{kappa}B heterodimers containing the p50 subunit were detected in 82% of group 1 patients, 14% of group 2 patients, and 21% of group 3 patients (p < 0.001; group 1 vs. group 2 and group 3). The figure shows the assessment of NF-{kappa}B activation in 3 patients (Pt) of group 1 and in 3 patients of group 2. (B) Enzyme-linked immunosorbent assay (ELISA) for active NF-{kappa}B p65. The amount of activated NF-{kappa}B p65 subunit in nuclear extract (5 µg), prepared from 5 x 105 monocytes was assessed by a sensitive ELISA assay for active NF-{kappa}B. The activated NF-{kappa}B p65 subunit was significantly higher in group 1 than in the other groups. ANOVA = analysis of variance; OD = optical density.





Right arrow Return to article

 
  cardiology careers collections past issues search home